[go: up one dir, main page]

CY1113959T1 - Χρηση λιποσωματων pvp-ιωδιου για θεραπεια ακμης - Google Patents

Χρηση λιποσωματων pvp-ιωδιου για θεραπεια ακμης

Info

Publication number
CY1113959T1
CY1113959T1 CY20131100342T CY131100342T CY1113959T1 CY 1113959 T1 CY1113959 T1 CY 1113959T1 CY 20131100342 T CY20131100342 T CY 20131100342T CY 131100342 T CY131100342 T CY 131100342T CY 1113959 T1 CY1113959 T1 CY 1113959T1
Authority
CY
Cyprus
Prior art keywords
iodium
pvp
liposomes
acne treatment
treatment
Prior art date
Application number
CY20131100342T
Other languages
English (en)
Inventor
Karen Reimer
Wolfgang Fleischer
Michael Hopp
Original Assignee
Euro-Celtique S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro-Celtique S.A. filed Critical Euro-Celtique S.A.
Publication of CY1113959T1 publication Critical patent/CY1113959T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/28—Mercury; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Η εφεύρεση αφορά σε μία μέθοδο για την παρασκευή ενός φαρμακευτικού παρασκευάσματος για την θεραπεία μορφών ακμής, που χαρακτηρίζεται από το ότι το παρασκεύασμα περιλαμβάνει τουλάχιστον μια αντισηπτική ένωση συνδυασμένη με έναν συγκεκριμένο φορέα.
CY20131100342T 2003-02-24 2013-04-25 Χρηση λιποσωματων pvp-ιωδιου για θεραπεια ακμης CY1113959T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03003281A EP1449533A1 (en) 2003-02-24 2003-02-24 Use of PVP-iodine liposomes for the treatment of acne
EP04710362.7A EP1596876B1 (en) 2003-02-24 2004-02-12 Use of pvp-iodine liposomes for treatment of acne

Publications (1)

Publication Number Publication Date
CY1113959T1 true CY1113959T1 (el) 2016-07-27

Family

ID=32731522

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20131100342T CY1113959T1 (el) 2003-02-24 2013-04-25 Χρηση λιποσωματων pvp-ιωδιου για θεραπεια ακμης

Country Status (11)

Country Link
US (2) US20060292244A1 (el)
EP (2) EP1449533A1 (el)
JP (1) JP2006518720A (el)
AR (1) AR044201A1 (el)
CY (1) CY1113959T1 (el)
DK (1) DK1596876T3 (el)
ES (1) ES2406455T3 (el)
PT (1) PT1596876E (el)
SI (1) SI1596876T1 (el)
TW (1) TW200501970A (el)
WO (1) WO2004073720A1 (el)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1449520A1 (en) * 2003-02-24 2004-08-25 Euro-Celtique S.A. Use of PVP-Iodine liposomes for treatment of herpes
US8580317B2 (en) 2005-03-30 2013-11-12 Revance Therapeutics, Inc. Compositions and methods for treating acne
JP6122035B2 (ja) * 2012-02-17 2017-04-26 ヴェローチェ・バイオファーマ・エルエルシー 皮膚および爪の治療のための抗真菌組成物
KR20180011882A (ko) * 2015-01-20 2018-02-02 벨로체 바이오파르마 엘엘씨 신규한 요오드포 조성물 및 사용 방법
US10265433B2 (en) 2015-03-18 2019-04-23 Lawrence Livermore National Security, Llc Hemorrhage management system
EP3310334A1 (en) 2015-06-22 2018-04-25 Infection Containment Company, LLC Topical antiseptic system
WO2017092818A1 (en) * 2015-12-03 2017-06-08 Symrise Ag Delivery system for active agents
WO2019005643A1 (en) * 2017-06-26 2019-01-03 Next Science IP Holdings Pty Ltd METHOD OF TREATING PATHOLOGIES OF COLLAGEN FIBERS
WO2022047042A1 (en) * 2020-08-26 2022-03-03 Oticara, Inc. Compositions devices and methods for treating nasal, otic and other tissue infection and/or inflammation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966090A (en) * 1969-02-17 1976-06-29 Dart Industries Inc. Package for dispensing an antiseptic composition
US3671545A (en) * 1969-05-05 1972-06-20 Synergistics Inc Polyvinylpyrrolidone-iodine compounds
US4497823A (en) * 1982-11-05 1985-02-05 Moore William T Therapeutic method to reduce pain and inflammation
US5038769A (en) * 1983-06-29 1991-08-13 Krauser Robert S Method and apparatus for treating ailments
US5409917A (en) * 1991-03-05 1995-04-25 Marvin S. Towsend Topical treatment of acne with cephalosporins
FR2714602B1 (fr) * 1993-12-30 1996-02-09 Oreal Composition antiacnéique pour le traitement simultané des couches superficielles et profondes de la peau, son utilisation.
US20030007939A1 (en) * 1998-07-31 2003-01-09 Howard Murad Pharmaceutical compositions and methods for managing dermatological conditions
EP1180017B8 (en) * 1999-05-27 2010-05-19 Euro-Celtique S.A. Preparations with povidon iodine for wound treatment
US6495158B1 (en) * 2001-01-19 2002-12-17 Lec Tec Corporation Acne patch
EP1449520A1 (en) * 2003-02-24 2004-08-25 Euro-Celtique S.A. Use of PVP-Iodine liposomes for treatment of herpes

Also Published As

Publication number Publication date
US20060292244A1 (en) 2006-12-28
EP1449533A1 (en) 2004-08-25
DK1596876T3 (da) 2013-05-06
PT1596876E (pt) 2013-05-21
WO2004073720A1 (en) 2004-09-02
EP1596876A1 (en) 2005-11-23
TW200501970A (en) 2005-01-16
US20120294933A1 (en) 2012-11-22
EP1596876B1 (en) 2013-04-10
JP2006518720A (ja) 2006-08-17
SI1596876T1 (sl) 2013-07-31
ES2406455T3 (es) 2013-06-07
AR044201A1 (es) 2005-09-07

Similar Documents

Publication Publication Date Title
CY1113959T1 (el) Χρηση λιποσωματων pvp-ιωδιου για θεραπεια ακμης
CY1109088T1 (el) Μεθοδος για την παρασκευη υποκατεστημενων ενωσεων 3-αρυλο-βουτυλ-αμινης
CY1119168T1 (el) Φαρμακευτικο παρασκευασμα που περιεχει οξυκωδονη και ναλοξονη
CY1122076T1 (el) Φυτικα εκχυλισματα που περιεχουν κανναβινοειδες σαν νευρο-προστατευτικοι παραγοντες
CY1110835T1 (el) Διφαινυλ παραγωγα και η χρηση τους στη θεραπεια της ηπατιτιδας c
CY1113003T1 (el) Ευσταθη παρασκευασματα laquinimod
CY1106722T1 (el) Περικαλυμμενη τσικλα
CY1107911T1 (el) Διαταξη αφαιρεσεως
CY1109240T1 (el) Συνδυασμος που περιλαμβανει βαλσαρτανη, αμλοδιπινη και υδροχλωροθειαζιδιο
CY1113963T1 (el) Φαρμακευτικες συνθεσεις οι οποιες περιλαμβανουν ανταγωνιστες ακτιβινης-actriia και χρηση αυτων στην προληψη η' θεραπευτικη αγωγη πολλαπλου μυελωματος
CY1114920T1 (el) Φαρμακευτικη συνθεση που περιεχει λακοσαμιδη και λεβετιρακεταμη με συνεργιστικη αντισπασμωδικη δραση
CY1111579T1 (el) Νεα συνδυασμενη χρηση μιας ενωσης σουλφοναμιδης (sulfonamide) στην θεραπεια του καρκινου
ATE469674T1 (de) 5-aminolävulinsäure-derivate zur behandlung von akne
ATE408601T1 (de) Fredericamycin-derivate
CY1116494T1 (el) Θεραπευτικη αγωγη θρομβοεμβολικων διαταραχων με ριβαροξαβανη
GB0019283D0 (en) Organic compounds
AR061446A1 (es) Utilizacion de la 1,7 -dimetilxantina para la fabricacion de un medicamento psicoanaleptico no ansiogeno destinado al tratamiento de un trastorno neuropsiquiatrico
AR050623A1 (es) Metodo para el tratamiento del trastorno de hiperactividad de deficit de atencion
TW200700071A (en) Novel use
CY1120368T1 (el) Αλληλουχια ειδικης διασπασης μμρ-14
HN2003000063A (es) Derivados de nicotinamida y una sal de tiotropio en combinacion para el tratamiento de enfermedades.
CY1114217T1 (el) Θεραπεια του μελανωματος
MX2010001303A (es) Compuestos terapeuticos.
CY1108916T1 (el) Υποκαθιστουμενες πυρρολες, οι ενωσεις που τις περιεχουν, διαδικασια παρασκευης και χρηση τους
CY1105699T1 (el) Νεες φαρμακευτικες ενωσεις με αλφα2υποδοχεα δραστηριοτητας